Trupanion (NASDAQ:TRUP) Given New $57.00 Price Target at Piper Sandler

Trupanion (NASDAQ:TRUP) had its target price lifted by Piper Sandler from $45.00 to $57.00 in a research report released on Thursday morning, Benzinga reports. They currently have a neutral rating on the financial services provider’s stock.

Other equities analysts have also issued research reports about the company. William Blair began coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating for the company. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Northland Securities lifted their price objective on shares of Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a research report on Thursday, September 19th. Stifel Nicolaus boosted their target price on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Finally, Bank of America lifted their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.

Trupanion Stock Performance

Trupanion stock traded up $0.80 during trading on Thursday, reaching $55.58. The company had a trading volume of 177,032 shares, compared to its average volume of 678,395. The firm has a market capitalization of $2.34 billion, a price-to-earnings ratio of -171.19 and a beta of 1.73. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm’s 50-day simple moving average is $46.92 and its 200 day simple moving average is $36.00. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative return on equity of 4.42% and a negative net margin of 1.08%. The business’s quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.10) EPS. Sell-side analysts forecast that Trupanion will post -0.34 earnings per share for the current fiscal year.

Insider Activity at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 640 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,764 shares of company stock worth $405,238. Insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in TRUP. GAMMA Investing LLC grew its stake in Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares in the last quarter. Headlands Technologies LLC bought a new position in Trupanion in the second quarter worth approximately $162,000. Handelsbanken Fonder AB bought a new position in Trupanion in the third quarter worth approximately $248,000. Oppenheimer Asset Management Inc. purchased a new position in Trupanion during the 2nd quarter worth $235,000. Finally, Bayesian Capital Management LP bought a new stake in Trupanion during the 1st quarter valued at $253,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.